XML 88 R74.htm IDEA: XBRL DOCUMENT v3.21.1
Equity Compensation (Summary of Outstanding Options Vesting, Expected to Vest, or Exercisable) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 27, 2021
Mar. 28, 2020
Mar. 30, 2019
Share-based Payment Arrangement, Noncash Expense [Abstract]      
Number of Options, Vested and expected to vest (in shares) 1,048    
Weighted Average Exercise Price, Vested and expected to vest (in dollars per share) $ 49.68    
Weighted Average Remaining Contractual Term, Vested and expected to vest 6 years 2 months 19 days    
Aggregate Intrinsic Value, Vested and expected to vest $ 34,926    
Number of Options, Exercisable (in shares) 737 800 1,300
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 44.91    
Weighted Average Remaining Contractual Term, Exercisable 5 years 3 months 7 days    
Aggregate Intrinsic Value, Exercisable $ 28,062